Analysis of postpartum hypertension in women with preeclampsia
- PMID: 37481613
- PMCID: PMC10739227
- DOI: 10.1038/s41371-023-00849-3
Analysis of postpartum hypertension in women with preeclampsia
Abstract
Postpartum hypertension including persistent and recurrent hypertension could significantly affect maternal morbidity in preeclampsia. Data on the postpartum management of women with preeclampsia is limited. The objective of this study was to investigate the details of women experiencing persistent postpartum hypertension (PerPPH) or developing recurrent postpartum hypertension (RecPPH) after birth and whether the treatment with anti-hypertensive drugs could shorten the hospital stay. We also compared the clinical parameters in women who developed RecPPH and who did not. Data on 188 preeclamptic women, including the severity or time of onset, duration of hospital admission postpartum, and blood pressure during the admission were collected and analyzed. Overall, 30% of preeclamptic women developed RecPPH on day 1, 13% on day 3, and 12% on day 5 after birth. Women with severe preeclampsia or early onset preeclampsia are more likely to develop RecPPH, compared to women with mild or late onset preeclampsia. The overall time in days before discharge was not different between women with normal blood pressure and women with abnormal blood pressure 1 h after birth, regardless of the severity or gestation of onset. However, women with severe or early onset preeclampsia stayed longer in the hospital, compared to women with mild or late onset preeclampsia. In addition, women with severe or early onset preeclampsia or early delivery increased risk of developing RecPPH. In conclusion, we demonstrate that RecPPH became apparent on day 1 after delivery, and hence close monitoring of blood pressure even if initially seemingly normal after birth is important.
© 2023. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
![Fig. 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10739227/bin/41371_2023_849_Fig1_HTML.gif)
![Fig. 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10739227/bin/41371_2023_849_Fig2_HTML.gif)
![Fig. 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10739227/bin/41371_2023_849_Fig3_HTML.gif)
Similar articles
-
Effectiveness of extended postpartum inpatient monitoring for hypertensive disorders of pregnancy to reduce the risk of readmission for preeclampsia with severe features.Am J Obstet Gynecol MFM. 2023 Jul;5(7):100956. doi: 10.1016/j.ajogmf.2023.100956. Epub 2023 Apr 4. Am J Obstet Gynecol MFM. 2023. PMID: 37023986
-
Postpartum preeclampsia or eclampsia: defining its place and management among the hypertensive disorders of pregnancy.Am J Obstet Gynecol. 2022 Feb;226(2S):S1211-S1221. doi: 10.1016/j.ajog.2020.10.027. Epub 2021 Jul 7. Am J Obstet Gynecol. 2022. PMID: 35177218 Free PMC article. Review.
-
Clinical Course, Associated Factors, and Blood Pressure Profile of Delayed-Onset Postpartum Preeclampsia.Obstet Gynecol. 2019 Nov;134(5):995-1001. doi: 10.1097/AOG.0000000000003508. Obstet Gynecol. 2019. PMID: 31599846 Free PMC article.
-
Torsemide for Prevention of Persistent Postpartum Hypertension in Women With Preeclampsia: A Randomized Controlled Trial.Obstet Gynecol. 2018 Nov;132(5):1185-1191. doi: 10.1097/AOG.0000000000002941. Obstet Gynecol. 2018. PMID: 30303905 Clinical Trial.
-
Etiology and management of postpartum hypertension-preeclampsia.Am J Obstet Gynecol. 2012 Jun;206(6):470-5. doi: 10.1016/j.ajog.2011.09.002. Epub 2011 Sep 16. Am J Obstet Gynecol. 2012. PMID: 21963308 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical